"10.1371_journal.pone.0045248","plos one","2012-09-17T00:00:00Z","Serge A L Zander; Wendy Sol; Lee Greenberger; Yixian Zhang; Olaf van Tellingen; Jos Jonkers; Piet Borst; Sven Rottenberg","Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pharmacology, Enzon Pharmaceuticals Inc., Piscataway, New Jersey, United States of America; Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands","Conceived and designed the experiments: SALZ SR PB JJ OvT. Performed the experiments: SALZ WS SR. Analyzed the data: SALZ PB SR. Contributed reagents/materials/analysis tools: LG YZ OvT. Wrote the paper: SALZ SR.","Sven Rottenberg has received research funding from ENZON Pharmaceuticals Inc. to perform the experiments with EZN-2208, Yixian Zhang is an employee of ENZON Pharmaceuticals Inc., who is sponsoring the clinical development of EZN-2208. Yixian Zhang and Lee Greenberger own shares of Enzon Pharmaceuticals Inc.","2012","09","Serge A L Zander","SALZ",8,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
